Literature DB >> 19187240

Kinetic and mechanistic characterization of Mycobacterium tuberculosis glutamyl-tRNA synthetase and determination of its oligomeric structure in solution.

Stefano Paravisi1, Gianluca Fumagalli, Milena Riva, Paola Morandi, Rachele Morosi, Peter V Konarev, Maxim V Petoukhov, Stéphane Bernier, Robert Chênevert, Dmitri I Svergun, Bruno Curti, Maria A Vanoni.   

Abstract

Mycobacterium tuberculosis glutamyl-tRNA synthetase (Mt-GluRS), encoded by Rv2992c, was overproduced in Escherichia coli cells, and purified to homogeneity. It was found to be similar to the other well-characterized GluRS, especially the E. coli enzyme, with respect to the requirement for bound tRNA(Glu) to produce the glutamyl-AMP intermediate, and the steady-state kinetic parameters k(cat) (130 min(-1)) and K(M) for tRNA (0.7 microm) and ATP (78 microm), but to differ by a one order of magnitude higher K(M) value for L-Glu (2.7 mm). At variance with the E. coli enzyme, among the several compounds tested as inhibitors, only pyrophosphate and the glutamyl-AMP analog glutamol-AMP were effective, with K(i) values in the mum range. The observed inhibition patterns are consistent with a random binding of ATP and L-Glu to the enzyme-tRNA complex. Mt-GluRS, which is predicted by genome analysis to be of the non-discriminating type, was not toxic when overproduced in E. coli cells indicating that it does not catalyse the mischarging of E. coli tRNA(Gln) with L-Glu and that GluRS/tRNA(Gln) recognition is species specific. Mt-GluRS was significantly more sensitive than the E. coli form to tryptic and chymotryptic limited proteolysis. For both enzymes chymotrypsin-sensitive sites were found in the predicted tRNA stem contact domain next to the ATP binding site. Mt-GluRS, but not Ec-GluRS, was fully protected from proteolysis by ATP and glutamol-AMP. Small-angle X-ray scattering showed that, at variance with the E. coli enzyme that is strictly monomeric, the Mt-GluRS monomer is present in solution in equilibrium with the homodimer. The monomer prevails at low protein concentrations and is stabilized by ATP but not by glutamol-AMP. Inspection of small-angle X-ray scattering-based models of Mt-GluRS reveals that both the monomer and the dimer are catalytically active. By using affinity chromatography and His(6)-tagged forms of either GluRS or glutamyl-tRNA reductase as the bait it was shown that the M. tuberculosis proteins can form a complex, which may control the flux of Glu-tRNA(Glu) toward protein or tetrapyrrole biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187240     DOI: 10.1111/j.1742-4658.2009.06880.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  8 in total

1.  Synthesis of Glu-tRNA(Gln) by engineered and natural aminoacyl-tRNA synthetases.

Authors:  Annia Rodríguez-Hernández; Hari Bhaskaran; Andrew Hadd; John J Perona
Journal:  Biochemistry       Date:  2010-08-10       Impact factor: 3.162

2.  Redox status affects the catalytic activity of glutamyl-tRNA synthetase.

Authors:  Assaf Katz; Rajat Banerjee; Merly de Armas; Michael Ibba; Omar Orellana
Journal:  Biochem Biophys Res Commun       Date:  2010-06-10       Impact factor: 3.575

3.  The archaeal transamidosome for RNA-dependent glutamine biosynthesis.

Authors:  Theodoros Rampias; Kelly Sheppard; Dieter Söll
Journal:  Nucleic Acids Res       Date:  2010-05-10       Impact factor: 16.971

Review 4.  Making proteins green; biosynthesis of chlorophyll-binding proteins in cyanobacteria.

Authors:  Roman Sobotka
Journal:  Photosynth Res       Date:  2013-02-04       Impact factor: 3.573

5.  Preliminary X-ray crystallographic analysis of an engineered glutamyl-tRNA synthetase from Escherichia coli.

Authors:  Nipa Chongdar; Saumya Dasgupta; Ajit Bikram Datta; Gautam Basu
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-06-18       Impact factor: 1.056

6.  Dispensability of zinc and the putative zinc-binding domain in bacterial glutamyl-tRNA synthetase.

Authors:  Nipa Chongdar; Saumya Dasgupta; Ajit Bikram Datta; Gautam Basu
Journal:  Biosci Rep       Date:  2015-03-31       Impact factor: 3.840

7.  Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target.

Authors:  Sudagar S Gurcha; Veeraraghavan Usha; Jonathan A G Cox; Klaus Fütterer; Katherine A Abrahams; Apoorva Bhatt; Luke J Alderwick; Robert C Reynolds; Nicholas J Loman; VijayaShankar Nataraj; Carlos Alemparte; David Barros; Adrian J Lloyd; Lluis Ballell; Judith V Hobrath; Gurdyal S Besra
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

8.  An anti-tuberculosis compound screen using a zebrafish infection model identifies an aspartyl-tRNA synthetase inhibitor.

Authors:  Eva Habjan; Vien Q T Ho; James Gallant; Gunny van Stempvoort; Kin Ki Jim; Coen Kuijl; Daan P Geerke; Wilbert Bitter; Alexander Speer
Journal:  Dis Model Mech       Date:  2021-12-23       Impact factor: 5.758

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.